Literature DB >> 31399296

Recombinant Elabela-Fc fusion protein has extended plasma half-life and mitigates post-infarct heart dysfunction in rats.

Yajing Wang1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31399296     DOI: 10.1016/j.ijcard.2019.06.043

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  1 in total

1.  Plasma levels of Elabela are associated with coronary angiographic severity in patients with acute coronary syndrome.

Authors:  Sheng-Li DU; Xin-Chun Yang; Jiu-Chang Zhong; Le-Feng Wang; Yi-Fan Fan
Journal:  J Geriatr Cardiol       Date:  2020-11-28       Impact factor: 3.327

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.